Acute pyelonephritis in pregnancy.
Acute pyelonephritis is one of the most common serious medical complications of pregnancy and may result in significant maternal morbidity. E. coli and Klebsiella are the two most common causative organisms. Pregnant women with acute pyelonephritis should be hospitalized and treated with parenteral antibiotics. Clinical response is usually dramatic, with the majority of patients being asymptomatic within 48 to 72 hours of therapy. Recurrent infection is common, and these women must be followed closely with frequent surveillance cultures. Detection and eradication of bacteriuria at the initial prenatal visit is important in preventing this complication.
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001437:Bacteriuria / Q000150:complications / Q000188:drug therapy; D005260:Female; D005440:Fluid Therapy; D006760:Hospitalization; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008171:Lung Diseases / Q000150:complications; D009582:Nitrofurantoin / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D011704:Pyelonephritis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*
D000900:Anti-Bacterial Agents; D009582:Nitrofurantoin